Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT

Oncolytics Biotech Cash Flow Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-31.71M -27.75M -24.84M -26.3M
Depreciation & Amortization
424K 403K 392K 452.06K
Stock-Based Compensation
2.72M 2.07M 2.38M 3.83M
Other Working Capital
3.59M 1.26M 46K -131.59K
Other Non-Cash Items
-1.94M -4.93M -1.68M 91.73K
Deferred Income Tax
n/a n/a n/a 408.56K
Change in Working Capital
3.54M 1.76M 391K -907.99K
Operating Cash Flow
-26.97M -28.45M -23.36M -22.43M
Capital Expenditures
-239K -8K -55K -285.95K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -20.35M n/a
Sales Maturities Of Investments
n/a 20.23M n/a n/a
Other Investing Acitivies
n/a n/a -20.35K n/a
Investing Cash Flow
-239K 20.22M -20.4M -285.95K
Debt Repayment
-348K -407K -381K -366K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
65K 781K 12K 469.68K
Financial Cash Flow
6.64M 31.99M 12.21M 33.02M
Net Cash Flow
-18.97M 23.25M -29.6M 10.04M
Free Cash Flow
-27.2M -28.46M -23.41M -22.72M